U.S. will share COVID-19 vaccine if it has surplus: Biden

U.S. will share COVID-19 vaccine if it has surplus: Biden

According to the office of United States president Joe Biden, one in four adults in the United States have so far been vaccinated against Covid-19. "This is war time, and as facts still emerge, it gives us maximum flexibility for our upcoming needs".

White House Press Secretary Jen Psaki told reporters that Biden was deeply focussed on expanding global vaccinations, but the USA government was pushing to first ensure sufficient doses for people in the United States who wanted to get vaccinated. A lot can happen. That being said, the USA must continue to improve the manufacturing and distribution of vaccines as the only way to guide this great nation to total recovery is to first, whether we like it or not, achieve herd immunity.

Earlier, the president lauded the "historic, almost unprecedented collaboration" between Johnson and Johnson and Merck as he underscored the move to secure an additional 100 million doses of Johnson and Johnson vaccine.

"Trump promises coronavirus vaccine by end of the year, but his own experts temper expectations", said an ABC News headline in May.

Unions call for nationwide strike in Myanmar as anti-coup campaign intensifies
Live footage posted to social media also showed a raid after nightfall on the offices of the Democratic Voice of Burma ( DVB ). The United Nations said Monday that the occupation of hospitals by security forces is "completely unacceptable".

It's not just Johnson and Johnson and Merck, Pfizer and Moderna also work closely with the administration to help speed up the delivery of millions more doses, he said.

"There is light at the end of this dark tunnel of this past year, but we can not let our guard down now or assume victory is inevitable. Together, we're gonna get through this pandemic and usher in a healthier and more hopeful future", he added.

He made the remarks at the White House standing next to Alex Gorsky, the CEO of Johnson & Johnson, and Ken Frazier, the CEO of Merck, during an event to celebrate the partnership between the two companies. "And today I'm directing Jeff and my HHS Team to produce another 100 million doses and purchase another 100 million dose of the Johnson and Johnson vaccine", he said.

Johnson & Johnson's Covid-19 vaccine was approved for emergency use on February 27. Johnson & Johnson also does not require specialized freezers or extremely low temperatures, making it a convenient option for longtime storage and distribution to rural communities.

Related Articles